Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MWX203 Alone or With Inclisiran in Mixed Dyslipidemia
NCT07803822Phase 2Recruiting
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd.
- Start
- Sep 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
A Phase 2 trial of MWX203 in mixed dyslipidemia, sponsored by Shanghai Minwei Biotechnology Co., Ltd.. Started Sep 2026; status: recruiting.
02
Drugs
MWX203
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT07803822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07803822.